Progress and challenges in TB vaccine development

Gérald Voss(Coalition for Epidemic Preparedness Innovations), Helen A. Fletcher(London School of Hygiene & Tropical Medicine)

F1000Research

February 16, 2018

10.12688/f1000research.13588.1

Cited by 114

Related Papers

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

|The Lancet|2001|528

A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

|Nature Medicine|2004|266

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

|Vaccine|2006|93